Burning Rock Biotech Limited(NASDAQ:BNR) 
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. The company primarily offers 12 next-generation sequencing-based cancer therapy selection tests applicable to a range of cancer types, including lung cancer, gastrointestina...
Website: http://www.brbiotech.com
Founded: 2014
Full Time Employees: 705
CEO: Yu Sheng Han
Sector: Healthcare
Industry: Diagnostics & Research
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.72
H 3.77
L 3.72
C 3.75
V 4,128
10EMA 3.75
20EMA 3.75
60EMA 3.75
120EMA 3.75
250EMA 3.75